Ophthalmic Devices
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT05281809
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Phase: Phase 2
Role: Collaborator
Start: Apr 19, 2022
Completion: Dec 1, 2037
Loading map...